BACKGROUND: An increased percentage of peripheral transitional B cells producing IL-10 has been observed in patients tolerant to kidney allografts. In healthy volunteers, the balance between the CD40 and B-cell receptor (BCR) signalling modulated IL-10 production by B cells, with stimulation via the BCR decreasing CD40-mediated IL-10 production. In this study, we evaluate whether in tolerant kidney transplant patients, the increased IL-10 production by B cells was due to an altered CD40 and/or BCR signalling. METHODS: B cells obtained from a new cohort of tolerant renal transplant recipients and those from age- and sex-matched healthy volunteers were activated via CD40 and BCR, either alone or in combination. RESULTS: In tolerant patients, we observed higher percentages of B cells producing IL-10 after CD40 ligation and higher expression of CD40L on activated T cells compared with healthy controls. Furthermore, B cells from tolerant recipients had reduced extracellular signal-regulated kinase signalling after BCR-mediated activation compared with healthy controls. In keeping with this, combining BCR signalling with CD40 ligation did not reduce IL-10 secretion as was observed in healthy control transitional B cells. CONCLUSIONS: Altogether, our data suggest that the altered response of B cells in tolerant recipients may contribute to long-term stable graft acceptance.
BACKGROUND: An increased percentage of peripheral transitional B cells producing IL-10 has been observed in patients tolerant to kidney allografts. In healthy volunteers, the balance between the CD40 and B-cell receptor (BCR) signalling modulated IL-10 production by B cells, with stimulation via the BCR decreasing CD40-mediated IL-10 production. In this study, we evaluate whether in tolerant kidney transplant patients, the increased IL-10 production by B cells was due to an altered CD40 and/or BCR signalling. METHODS: B cells obtained from a new cohort of tolerant renal transplant recipients and those from age- and sex-matched healthy volunteers were activated via CD40 and BCR, either alone or in combination. RESULTS: In tolerant patients, we observed higher percentages of B cells producing IL-10 after CD40 ligation and higher expression of CD40L on activated T cells compared with healthy controls. Furthermore, B cells from tolerant recipients had reduced extracellular signal-regulated kinase signalling after BCR-mediated activation compared with healthy controls. In keeping with this, combining BCR signalling with CD40 ligation did not reduce IL-10 secretion as was observed in healthy control transitional B cells. CONCLUSIONS: Altogether, our data suggest that the altered response of B cells in tolerant recipients may contribute to long-term stable graft acceptance.
Authors: Fabian Flores-Borja; Anneleen Bosma; Dorothy Ng; Venkat Reddy; Michael R Ehrenstein; David A Isenberg; Claudia Mauri Journal: Sci Transl Med Date: 2013-02-20 Impact factor: 17.956
Authors: G Roussey-Kesler; M Giral; A Moreau; J-F Subra; C Legendre; C Noël; E Pillebout; S Brouard; J-P Soulillou Journal: Am J Transplant Date: 2006-04 Impact factor: 8.086
Authors: Paul A Blair; Lina Yassin Noreña; Fabian Flores-Borja; David J Rawlings; David A Isenberg; Michael R Ehrenstein; Claudia Mauri Journal: Immunity Date: 2010-01-14 Impact factor: 31.745
Authors: Aravind Cherukuri; David M Rothstein; Brendan Clark; Clive R Carter; Adam Davison; Maria Hernandez-Fuentes; Eric Hewitt; Alan D Salama; Richard J Baker Journal: J Am Soc Nephrol Date: 2014-03-07 Impact factor: 10.121
Authors: Sarah E Panzer; Nancy A Wilson; Bret M Verhoven; Ding Xiang; C Dustin Rubinstein; Robert R Redfield; Weixiong Zhong; Shannon R Reese Journal: Transplantation Date: 2018-03 Impact factor: 4.939
Authors: Diego Catalán; Miguel Andrés Mansilla; Ashley Ferrier; Lilian Soto; Kristine Oleinika; Juan Carlos Aguillón; Octavio Aravena Journal: Front Immunol Date: 2021-04-29 Impact factor: 7.561
Authors: I Rebollo-Mesa; E Nova-Lamperti; P Mobillo; M Runglall; S Christakoudi; S Norris; N Smallcombe; Y Kamra; R Hilton; S Bhandari; R Baker; D Berglund; S Carr; D Game; S Griffin; P A Kalra; R Lewis; P B Mark; S Marks; I Macphee; W McKane; M G Mohaupt; R Pararajasingam; S P Kon; D Serón; M D Sinha; B Tucker; O Viklický; R I Lechler; G M Lord; M P Hernandez-Fuentes Journal: Am J Transplant Date: 2016-08-08 Impact factor: 8.086
Authors: Sofia Christakoudi; Manohursingh Runglall; Paula Mobillo; Irene Rebollo-Mesa; Tjir-Li Tsui; Estefania Nova-Lamperti; Catharine Taube; Sonia Norris; Yogesh Kamra; Rachel Hilton; Titus Augustine; Sunil Bhandari; Richard Baker; David Berglund; Sue Carr; David Game; Sian Griffin; Philip A Kalra; Robert Lewis; Patrick B Mark; Stephen D Marks; Iain MacPhee; William McKane; Markus G Mohaupt; Estela Paz-Artal; Sui Phin Kon; Daniel Serón; Manish D Sinha; Beatriz Tucker; Ondrej Viklický; Daniel Stahl; Robert I Lechler; Graham M Lord; Maria P Hernandez-Fuentes Journal: EBioMedicine Date: 2020-07-21 Impact factor: 8.143
Authors: Brian Ezekian; Paul M Schroder; Kyle Freischlag; Janghoon Yoon; Jean Kwun; Stuart J Knechtle Journal: Transplantation Date: 2018-08 Impact factor: 4.939
Authors: Estefania Nova-Lamperti; Marco Romano; Sofia Christakoudi; Manohursingh Runglall; Reuben McGregor; Paula Mobillo; Yogesh Kamra; Tjir-Li Tsui; Sonia Norris; Susan John; Dominic A Boardman; Robert I Lechler; Giovanna Lombardi; Maria P Hernandez-Fuentes Journal: Transplantation Date: 2018-01 Impact factor: 4.939